Our results showed that high PRDX4 level was related to a favorable OS for endometrioid cancer patients and a better PFS for all ovarian cancer patients, serous cancer patients, and endometrioid cancer patients. The gene discussed is PRDX4; the disease is ovarian carcinoma.